News

Filter

Current filters:

Ipsen

1 to 9 of 321 results

Ipsen pays 6 million euros for option to acquire Canbex

24-02-2015

French drugmaker Ipsen today announced that UK-based biotech firm Canbex Therapeutics has granted an…

BiotechnologyCanbex TherapeuticsIpsenMergers & AcquisitionsNeurologicalVSN16R

Ipsen reports strong performance by specialty care and solid overall growth for 2014

Ipsen reports strong performance by specialty care and solid overall growth for 2014

03-02-2015

French drugmaker Ipsen has reported solid growth for 2014, driven by good performance in its specialty…

DecapeptylDysportFinancialFranceIpsenPharmaceuticalSomatuline

Ipsen's Dysport gives positive results in adult and pediatric lower limb spasticity

Ipsen's Dysport gives positive results in adult and pediatric lower limb spasticity

26-01-2015

French drugmaker Ipsen has announced top line results from two double-blind Phase III trials of Dysport…

CNS DiseasesDysportFranceIpsenPharmaceuticalResearch

Ipsen appoints François Garnier as executive vice president, general counsel

Ipsen appoints François Garnier as executive vice president, general counsel

17-12-2014

French drugmaker Ipsen has appointed François Garnier as executive vice president, general counsel of…

BoardroomFranceIpsenIpsen GroupPharmaceutical

FDA approves Ipsen's Somatuline for metastatic gastroentero pancreatic neuroendocrine tumors

FDA approves Ipsen's Somatuline for metastatic gastroentero pancreatic neuroendocrine tumors

17-12-2014

The US Food and Drug Administration has approved Somatuline Depot (lanreotide) injection 120mg, manufactured…

IpsenOncologyPharmaceuticalRegulationSomatulineUSA

Ipsen Phase III trial shows benefits of combining tamoxifen and triptorelin in breast cancer survival

Ipsen Phase III trial shows benefits of combining tamoxifen and triptorelin in breast cancer survival

12-12-2014

French drugmaker Ipsen has announced results of a trial evaluating the use of ovarian suppression as…

DecapeptylFranceIpsenOncologyPharmaceuticalResearchtamoxifentriptorelin pamoate

Ipsen’s Dysport accepted for review by US FDA

Ipsen’s Dysport accepted for review by US FDA

28-11-2014

French drugmaker Ipsen says that the US Food and Drug Administration has accepted for review its supplemental…

DysportIpsenNeurologicalPharmaceuticalRegulationUSA

Ipsen partners with academia to launch Archi-Pex research site

Ipsen partners with academia to launch Archi-Pex research site

21-11-2014

French drugmaker Ipsen and the French National Center for Scientific Research are to launch the Archi-Pex…

Cross-linked polyethyleneFranceIpsenPharmaceuticalProductionResearchSoftware

1 to 9 of 321 results

Back to top